Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company.
A number of equities analysts have commented on RBGLY shares. Jefferies Financial Group raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Tuesday, July 21st. BNP Paribas Exane cut shares of Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a research note on Wednesday, September 2nd. Zacks Research upgraded shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a report on Friday, August 28th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research report on Tuesday, June 30th. Finally, The Goldman Sachs Group upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday.
View Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Up 0.9%
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc, now known as Reckitt, is a United Kingdom-based consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets products intended to support personal health, household cleanliness and hygiene.
Its brand portfolio includes consumer health products such as Nurofen, Strepsils, Mucinex and Durex, as well as household and hygiene brands including Dettol, Lysol, Finish and Vanish. Reckitt’s products are sold through retailers, pharmacies, e-commerce platforms and other distribution channels.
The company was formed in 1999 through the merger of Reckitt & Colman and Benckiser.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
